Promosyon programı CARGO Therapeutics, Inc.
Gelişmiş program
Basit grafik
Şirket hakkında
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. Daha fazla ayrıntı| EBITDA | -0.0057 |
|---|---|
| EV/EBITDA | -0.5483 |
| IPO date | 2023-11-10 |
| Industry | Biotechnology |
| P/BV | 2.35 |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://cargo-tx.com |
| Цена ао | 20.1 |
| Число акций ао | 0.04121 млрд |
| Günlük fiyat değişimi: | +12.29% (17.9) |
|---|---|
| Haftalık fiyat değişimi: | +8.94% (18.45) |
| Aylık fiyat değişimi: | +4.63% (19.21) |
| 3 ayda fiyat değişimi: | +22.64% (16.39) |
| Altı ayda fiyat değişimi: | -4.33% (21.01) |
| Yıllık fiyat değişimi: | 0% (20.1) |
| 3 yılda fiyat değişimi: | 0% (20.1) |
| 5 yılda fiyat değişimi: | 0% (20.1) |
| 10 yılda fiyat değişimi: | 0% (20.1) |
| Yılbaşından bu yana fiyat değişimi: | 0% (20.1) |
|
|
Hafife alma
|
Yeterlik
|
|||||||||||||||||||||||||||||||||||||
Temettüler
|
Görev
|
Büyüme dürtüsü
|
|||||||||||||||||||||||||||||||||||||
| Kurumlar | Hacim | Paylaşmak, % |
|---|---|---|
| Franklin Resources, Inc. | 575920 | 1.4 |
| Citigroup Inc. | 123176 | 0.3 |
| Charles Schwab Investment Management, Inc. | 110395 | 0.27 |
| Norges Bank Investment Management | 48797 | 0.12 |
| Bank Of New York Mellon Corporation | 17067 | 0.04 |
| New York State Common Retirement Fund | 807 | 0 |
| Atwood & Palmer Inc. | 350 | 0 |
| Allworth Financial Lp | 165 | 0 |
| Wells Fargo & Company | 143 | 0 |
| ETF | Paylaşmak, % | Yıllık karlılık, % | Temettüler, % |
|---|---|---|---|
| iShares Morningstar Small-Cap ETF | 0.00787 | 30.095066471445 | 1.60498 |
| iShares Micro-Cap ETF | 0.20747 | 11.903735012508 | 1.54048 |
| iShares Russell 2000 Growth ETF | 0.00608 | 38.042556988 | 0.6026 |
| iShares Russell 3000 ETF | 0.00189 | 23.534583821805 | 1.43482 |
| iShares Morningstar Small-Cap ETF | 0.00787 | 391.25300933451 | 1.60498 |
| iShares MSCI USA Small-Cap Min Vol Factor ETF | 0.05555 | 15.907184791725 | 1.66828 |
| Süpervizör | İş unvanı | Ödeme | Doğum yılı |
|---|---|---|---|
| Ms. Gina Chapman | President, CEO & Director | 1.09M | 1967 (57 yıllar) |
| Dr. Crystal L. Mackall M.D. | Co-Founder | 160k | 1961 (63 yıl) |
| Dr. Shishir Gadam Ph.D. | Chief Technical Officer | 674.03k | 1968 (56 yıllar) |
| Dr. Robbie Majzner M.D. | Founder & Chair of Scientific Advisory Board | N/A | |
| Ms. Nancy Goodman J.D. | Founder | N/A | |
| Dr. Louai Labanieh | Founder | N/A | |
| Mr. Anup Radhakrishnan | CFO, Secretary & Chief Business Officer | 667.1k | 1980 (44 yıl) |
| Mr. Faisal Shawwa M.B.A. | Senior Vice President of Finance & Accounting | N/A | |
| Dr. Michael Ports Ph.D. | Chief Scientific Officer | N/A | 1982 (42 yıl) |
| Dr. Ginna G. Laport M.D. | Chief Medical Officer | 538.13k | 1965 (59 yıllar) |
Adres: United States, San Mateo. CA, 1900 Alameda De Las Pulgas - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://cargo-tx.com
Web sitesi: https://cargo-tx.com
